BASTA JAMES 4
4 · Intellia Therapeutics, Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
BASTA JAMES
EVP, General Counsel
Transactions
- Award
Common Stock
2023-03-01+24,539→ 44,098 total - Award
Common Stock
2023-03-01+12,269→ 56,367 total - Sale
Common Stock
2023-03-02$43.88/sh−1,088$47,741→ 55,279 total - Award
Stock Option (right to buy)
2023-03-01+34,674→ 34,674 totalExercise: $40.75Exp: 2033-02-28→ Common Stock (34,674 underlying)
Footnotes (3)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on March 1, 2023.
- [F3]This option was granted on March 1, 2023 with respect to shares of Common Stock, with 33% vesting on January 1, 2024 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.